0

Pyroxamide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP382180178
CAS382180-17-8
Structure
MDL NumberMFCD13194970
Molecular Weight265.31
InChI KeyPTJGLFIIZFVFJV-UHFFFAOYSA-N
Description≥97% (HPLC)
SolubilityDMSO: 10 mg/mL (clear solution)
Assay≥97% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Causal Network Analysis of Head and Neck Keloid Tissue Identifies Potential Master Regulators

Laura Garcia-Rodriguez, Lamont Jones, Kang Mei Chen, Indrani Datta, George Divine, Maria J Worsham

Laryngoscope. 2016 Oct;126(10):E319-24.

PMID: 26990118

1

Histone Deacetylase Inhibitors and Anticancer Therapy

G Kouraklis, S Theocharis

Curr Med Chem Anticancer Agents. 2002 Jul;2(4):477-84.

PMID: 12678732

1

Histone Deacetylase Inhibitors Induce Growth Suppression and Cell Death in Human Rhabdomyosarcoma in Vitro

Martha C Kutko, Richard D Glick, Lisa M Butler, Dennis C Coffey, Richard A Rifkind, Paul A Marks, Victoria M Richon, Michael P LaQuaglia

Clin Cancer Res. 2003 Nov 15;9(15):5749-55.

PMID: 14654560

1

Histone Deacetylase Inhibitors: A Novel Target of Anticancer Therapy (Review)

Gregory Kouraklis, Stamos Theocharis

Oncol Rep. 2006 Feb;15(2):489-94.

PMID: 16391874

1

Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase

L M Butler, Y Webb, D B Agus, B Higgins, T R Tolentino, M C Kutko, M P LaQuaglia, M Drobnjak, C Cordon-Cardo, H I Scher, R Breslow, V M Richon, R A Rifkind, P A Marks

Clin Cancer Res. 2001 Apr;7(4):962-70.

PMID: 11309347

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode